Los anticoagulantes orales de acción directa (ACOD) son fármacos que han demostrado tener un perfil de seguridad superior a los antivitamina K (AVK). En España la prescripción …
Las enfermedades del sistema circulatorio son la primera causa de muerte para el conjunto de la población española. En el año 2016 causaron en España 119.778 muertes (55.307 en …
JM Lobos-Bejarano, V Barrios… - … medical research and …, 2016 - Taylor & Francis
Objective: To assess the major clinical factors affecting the quality of anticoagulation and evaluate the predictive value of the SAMe-TT2R2 score to identify patients who will achieve …
JM Mostaza, C Suarez, JM Cepeda, L Manzano… - BMC Cardiovascular …, 2021 - Springer
Background This study assessed the sociodemographic, functional, and clinical determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation (NVAF) …
JP García, DV Ortega, F Formiga, I Unzueta… - Medicina de Familia …, 2019 - Elsevier
Objective In non-valvular atrial fibrillation (NVAF) with embolic risk, the guidelines recommend oral anticoagulation (OAC), although not all patients receive it. In this study, an …
AM Galán, CB Cuixart, JRB Banegas, EM Rioboó… - Atención …, 2016 - sahta.com
Las enfermedades del sistema circulatorio son la primera causa de muerte para el conjunto de la población española. En el año 2013 causaron en España 117.484 muertes (53.487 en …
Background To describe trends in the incidence and outcomes for atrial fibrillation (AF) in patients with and without type 2 diabetes (T2DM) in Spain between 2004 and 2013 …
D Orozco-Beltran, JA Quesada… - Scientific Reports, 2020 - nature.com
This study aimed to assess atrial fibrillation (AF) incidence and predictive factors in hypertensive patients and to formulate an AF risk assessment score that can be used to …
Objectives To determine the degree of risk factor control, the clinical symptoms and the therapeutic management of patients with a history of previous myocardial infarction …